aesku kipp schildThe AESKU.KIPP INSTITUTE initiates and coordinates international research cooperation and development projects in autoimmunity. At the same time it offers the spatial and personnel requirements for the implementation of joint interdisciplinary projects at the Wendelsheim facility.

As early as 2003 Dr. h.c. Karl-Heinz Kipp and the company AESKU.DIAGNOSTICS, in cooperation with the Laura Schwartz-Kipp Foundation, set a fresh milestone in autoimmunity research with the establishment of this first chair for autoimmunity.

A future-oriented event forum is being created at the AESKU.KIPP INSTITUTE, including meetings between leading scientists, contribution to PhD degree programs further training of doctors and laboratories as well as information events for patients.

The AESKU.KIPP INSTITUTE has consciously positioned itself as an international interface between basic and clinical research, so that recent research results may be integrated into clinical applications.

The organization AIRA e.V. (Association for interdisziplinary research in autoimmunity) intentionally commits itself to promoting interdisciplinary research in autoimmunity. The AESKU.KIPP INSTITUTE will provide a novel and unique type of support for international research projects by offering in-house space and technical equipment.

Being a nonprofit association, the AESKU.KIPP INSTITUTE will intentionally create openness towards a diversity of cooperation partners in science and economy, thus providing an ideal environment for the interdisciplinary orientation of its activities and the generation of true benefit for the public.

Alone the composition of the founder members reflects the intended interdisciplinarity of the association. Basic and clinical research, product development, lab organization and knowledge management and marketing – all these different experiences and fields of knowledge will be combined to form an ideal background for the AESKU.KIPP INSTITUTE.

For continuing further development of its research and to establish and maintain an internationally leading position, the AESKU.KIPP INSTITUTE requires a structure enabling unbureaucratic work.

A slim and flexible organization will be the basis of frictionless and efficient cooperation with research institutions, companies and other organizations.

The management of the AESKU.KIPP INSTITUTE will be composed of the two-people AIRA board and the AIRA management.

Coordinators will be in charge of the timely and consequent development of the interdisciplinary research coordination projects.

The institute offers its cooperation partners a spatial and technological basis for joint research projects and also organizational and financial support.

AIRA board

boardDr. Torsten Matthias, chairman of the board of the AIRA e.V.:

“Based on interdisciplinary networking of international scientific competence and intended orientation towards practical issues, the AESKU.KIPP INSTITUTE will be a unique interface between basic research, clinical research and product development.“

Dr. Torsten Witte, Medical University Hannover, deputy chairman of the board AIRA e.V.:

“Only the ‘look beyond the nose’ will help to implement new diagnostic strategies and therapeutic options for autoimmune diseases in the near future.“

To create a unique platform for interdisciplinary research in autoimmunity, the support of committed individuals is essential in order to initiate and to guarantee the realization of future-oriented research and development projects. Therefore, the AESKU.KIPP INSTUTUTE will be supported by an active advisory council of experts in autoimmunity committed o the aims of the institute.

The scientific advisory council is to advise the association and the institute on the content and orientation of the research projects. At the same time it will also establish contact to international research groups, assisting the association and institute in the initiation and coordination of new projects. The council will be elected for a period of three years by the members’ assembly of the AIRA association, following proposals by the chair.

Members of the scientific advisory Board

Ten international experts in autoimmunity support the AESKU.KIPP INSTITUTE actively.


Yehuda ShoenfeldYehuda Shoenfeld
MD. FRCP(Hon.)University of Tel Aviv, Israel

noel roseNoel R. Rose, M.D. Ph.D.
Johns Hopkins Medical Institute, Baltimore, USA

helmkeProf. Dr. Klaus Helmke
Munich-Bogenhausen Hospital, Germany

schmidtProf. Dr. Reinhold E. Schmidt
Hanover Medical University, Germany

gershwinM. Eric Gershwin
M.D., University of California at Davis, USA

guilevinLoïc Guillevin
PU-PH, Hôpital Cochin, Université Paris Descartes, France

steinProf. Dr. Dr. Jürgen Stein
University of Frankfurt, Germany

maeurerProf. Dr. Markus J. Maeurer
Smittskyddsinstitutet, Solna, Sweden

wiikAllan Wiik, M.D. DSc
Department of Autoimmunology, Statens Serum Institute, Copenhagen, Denmark

meroniProf. Pier Luigi Meroni
IRCCS Istituto Auxologico Italiano,
Milano, Italy

A public private partnership will lay the foundation stone of the financing of the AESKU.KIPP INSTITUTE. The activities of the institute will be promoted by the financial support of the initiators of the AIRA e.V., i.e.

Dr. Torsten Matthias, proprietor of AESKU.DIAGNOSTICS and the Swiss private investor Dr. h.c. Karl-Heinz Kipp. In addition, the Economics Department of state of Rhineland-Palatinate granted parts of the equipment AESKU.KIPP INSTITUTE’s laboratory.

The implementation of current research projects into developmental projects involves the increasing cooperation of the AESKU.KIPP INSTITUTE with commercial enterprises, within the limits laid down by the supporting association AIRA e.V.

Dr. Torsten Matthias

Dr. Torsten Matthias, founder and owner of AESKU.DIAGNOSTICS, has extensive experience in research and development. For nearly two decades, his professional work and activities focused on the topic of autoimmunity.

A number of awards are testimony to the highly innovative character of the company and the unique selling points of the products.

- “Pioniergeist 2000”, award from the state of Rhineland-Palatinate for the business concept.

- “Innovation Prize 2001” from the state of Rhineland-Palatinate for the development of the patented alpha-fodrin test.

The clear objective of the research and development work of Dr. Torsten Matthias is, above all, the development of innovative and, at the same time, market-oriented diagnostics and therapies. Alongside the further positive development of the company, Dr. Torsten Matthias is pursuing the objective of attaining the close networking of interdisciplinary research in the fields of the pathogenesis, diagnosis and therapy of autoimmune diseases, and of guaranteeing such a network in the long term.

Dr. h.c. Karl-Heinz Kipp

Dr. h.c. Karl-Heinz Kipp began his extraordinary career as an entrepreneur as long ago as 1948 with the acquisition of the Trier-based national costume shop “Trierer Trachten und Bänderhandlung Alfred Massa”. In 1965, he founded the first Massa consumer market and then rapidly rose through the ranks of the leading self-service stores with unique concepts.

In line with his strong ties to his first business headquarters in Alzey, he invested in the development of the high technology centre MikroForum in Wendelsheim near Alzey.

In 2003, together with the company AESKU.DIAGNOSTICS, Wendelsheim, and in cooperation with the Laura Schwartz- Kipp Foundation established by himself, he supported the creation of the world’s first chair for autoimmunity at the University of Tel Aviv, Israel.

Karl-Heinz Kipp supports the development of the AESKU.KIPP INSTITUTE as a private investor, so as to promote research into autoimmunity, and to open up new development opportunities for the MikroForum and for the Rhineland-Palatinate as a research location.